author-placeholder

Prof Mark Jenkins

Director of the Centre for Epidemiology and Biostatistics, University of Melbourne
Director of the Centre for Epidemiology and Biostatistics, University of Melbourne

More from this expert

Clinical Articles iconClinical Articles

Menopause is a normal life stage for women at around 51 years. Most women don’t need treatment for their symptoms, but around 13% of Australian women aged 50-69 take menopausal hormone therapy (sometimes called “hormone replacement therapy”).This medication contains hormones that are normally low or absent after menopause, and reduces symptoms such as hot flushes and night sweats, which can be troublesome and persistent for some women.But growing evidence over recent years has pointed to an increased risk of breast cancer associated with menopausal hormone therapy. This has already led some women to stop or avoid the treatment.

Menopause is a normal life stage for women at around 51 years. Most women don’t need treatment for their symptoms, but around 13% of Australian women aged 50-69 take menopausal hormone therapy (sometimes called “hormone replacement therapy”).This medication contains hormones that are normally low or absent after menopause, and reduces symptoms such as hot flushes and night sweats, which can be troublesome and persistent for some women.But growing evidence over recent years has pointed to an increased risk of breast cancer associated with menopausal hormone therapy. This has already led some women to stop or avoid the treatment.

Clinical Articles iconClinical Articles

Upcoming Healthed Webcast

MHT and its cardiovascular benefits

Tuesday 28th October, 7pm - 9pm AEDT

Speaker

Prof Rodney Baber AM

Obstetrician and Gynaecologist; Clinical Professor, Obstetrics and Gynaecology, The University of Sydney

We invite you to our next free webcast, where Prof Rod Baber will present on menopausal hormone therapy. Up to 4 hours CPD. RACGP & ACRRM accredited.